Welcome to the Psychedelic Spotlight podcast. In this episode, the Psychedelic Investor sits down with Dr. Carol Routledge, Chief Scientific and Chief Medical Officer of Small Pharma (TSX.V: DMT, OTC: DMTTF). Dr. Carol Routhledge is an expert in psychedelic medicines, and she specializes in DMT.

In this interview, we attempted to answer the following questions:

What happens when you take DMT?

Can DMT help with depression?

Is DMT safe?

Small Pharma is a company that I am very excited about, as they are focussing on the psychedelic DMT, which I believe to have unlimited potential as a mental health drug.

Small Pharma is currently running a phase 2 Clinical Trial Attempting to treat Major Depressive Disorder using DMT, the world’s furthest progress DMT Study. We can expect results by the end of the year. If they are successful, the company will begin a phase 3 trial.

#DMT #SmallPharma #depression

Similar Posts

SAiD: Spiritual Aid in Dying: Psychedelics, MAiD, and Fully Informed Consent

SAiD: Spiritual Aid in Dying: Psychedelics, MAiD, and Fully Informed Consent

Learn, OPINION

If our current methods, practices, and thoughts about Hospice and Palliative Care, and end-of-life attitudes and knowledge in general, would change, MAiD wouldn’t be necessary in most cases, but it should be an accessible option and choice for everyone that we then don’t need to exercise. Shifting the focus to the surrounding suffering would, in-and-of itself, present many different options. 

Is ‘The Trip’ Essential to The Psychedelic Experience?

Is ‘The Trip’ Essential to The Psychedelic Experience?

Learn, Research

Biology and experience are tough to separate, but some researchers are exploring the possibility of non-hallucinogenic psychedelics as a mental health treatment. This begs the question: what do we lose, and what do we gain when we take the trip out of the psychedelic experience?